Cite Filings / IMVT / 0001172661-26-003481

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Immunovant, Inc. Filed 2026-08-14 Acc 0001172661-26-003481

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-21 4 Chief Operating Officer sold 3,056 shares at $44.16 ($134,953)
2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-05 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…